U.S. Retail Clinics Market Size, Share & Trends Analysis Report By Ownership (Retail Owned, Hospital Owned), By Diagnosis (Immunization, General Symptoms, General Screening & Examination, Injuries), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Tablet Market Report Highlights
The U.S. tablet market size is expected to reach USD 14.08 billion by 2030, registering a CAGR of 1.5% from 2024 to 2030, according to a new report by Grand View Research, Inc.Consumer electronics manufacturers are introducing advanced devices in the market to cater to the evolving technological awareness of consumers. Introduction of hybrid tablet PCs is the biggest factor fostering market growth over during the forecast period. Hybrid tablet PCs include detachable, convertibles, and slate tablet PCs. These hybrid devices are portable, easy to use, and high performance.
Hybrid PCs are gaining momentum in the tablet market due to various form factors. The convertible and detachable tablet PCs are easy to use as the keyboard is easy to detach and attach. Moreover, despite the presence of high-end tablets; conventional operating system tablets are projected to attract consumers in the forthcoming years. Consumer preference for efficient cost, ease of use, and battery life is anticipated to positively influence the market expansion.
Hybrid tablet PCs are increasingly being used in business, medicine, commercial, and defense areas. Moreover, although the sale of tablet PCs is projected to decline over the next years, traditional tablet PCs are projected to witness growth in sales in near future. Introduction of phablets in the consumer electronics market is projected to hamper growth of the tablet market. Moreover, other factors such as high cost, data security, and technical challenges such as absence of USB ports and traditional keyboards may hinder market growth over the forecast period.
The tablet market is projected to experience a decline due to the strong presence of large smartphones or phablets. Furthermore, tablets are used only for entertainment, gaming, and online video streaming activities. The sale of tablets is expected to experience a decline in U.S. due to the presence of large smartphone manufacturers and increasing smartphones users. Prominent tablet vendors are Apple Inc.; Samsung Electronics Co., Ltd.; ASUSTek Computer Inc.; and Amazon.com, Inc.
U.S. Tablet Market Report Highlights
U.S. Tablet Market Report Highlights
The U.S. tablet market size is expected to reach USD 14.08 billion by 2030, registering a CAGR of 1.5% from 2024 to 2030, according to a new report by Grand View Research, Inc.Consumer electronics manufacturers are introducing advanced devices in the market to cater to the evolving technological awareness of consumers. Introduction of hybrid tablet PCs is the biggest factor fostering market growth over during the forecast period. Hybrid tablet PCs include detachable, convertibles, and slate tablet PCs. These hybrid devices are portable, easy to use, and high performance.
Hybrid PCs are gaining momentum in the tablet market due to various form factors. The convertible and detachable tablet PCs are easy to use as the keyboard is easy to detach and attach. Moreover, despite the presence of high-end tablets; conventional operating system tablets are projected to attract consumers in the forthcoming years. Consumer preference for efficient cost, ease of use, and battery life is anticipated to positively influence the market expansion.
Hybrid tablet PCs are increasingly being used in business, medicine, commercial, and defense areas. Moreover, although the sale of tablet PCs is projected to decline over the next years, traditional tablet PCs are projected to witness growth in sales in near future. Introduction of phablets in the consumer electronics market is projected to hamper growth of the tablet market. Moreover, other factors such as high cost, data security, and technical challenges such as absence of USB ports and traditional keyboards may hinder market growth over the forecast period.
The tablet market is projected to experience a decline due to the strong presence of large smartphones or phablets. Furthermore, tablets are used only for entertainment, gaming, and online video streaming activities. The sale of tablets is expected to experience a decline in U.S. due to the presence of large smartphone manufacturers and increasing smartphones users. Prominent tablet vendors are Apple Inc.; Samsung Electronics Co., Ltd.; ASUSTek Computer Inc.; and Amazon.com, Inc.
U.S. Tablet Market Report Highlights
- The iOS segment dominated in 2023 with a market share of 42.6%. This is attributed to Apple's brand name and loyal customers who trust Apple's product quality and reliability.
- The Android segment is projected to grow at a CAGR of 1.5% over the forecast period. This is due to Android’s large portfolio of competitively priced products that target consumers at different levels.
- The 768 x 1024 segment held a significant market share in 2023 due to its affordability and sufficient resolution for common tasks such as reading, web browsing, and prolonged screen time.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. RETAIL CLINICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Retail Clinics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. U.S. RETAIL CLINICS MARKET: OWNERSHIP ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Retail Clinics Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
4.3. Retail Owned
4.3.1. Retail Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4. Hospital Owned
4.4.1. Hospital Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 5. U.S. RETAIL CLINICS MARKET: DIAGNOSIS ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Retail Clinics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
5.3. Immunization
5.3.1. Immunization Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. General Symptoms
5.4.1. General Symptoms Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5. Injuries
5.5.1. Injuries Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6. General Screening & Examination
5.6.1. General Screening & Examination Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.7. Acute Respiratory Disease & Infection
5.7.1. Acute Respiratory Disease & Infection Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.8. Urinary Tract Infections
5.8.1. Urinary Tract Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.9. Ear Infections
5.9.1. Ear Infections Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.10. Sprains, Strains, and Fractures
5.10.1. Sprains, Strains, and Fractures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.11. Others
5.11.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 6. U.S. RETAIL CLINICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. U.S. Retail Clinics Market Share, By Region, 2023 & 2030, USD Million
6.2. Southeast
6.2.1. Southeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3. Midwest
6.3.1. Midwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4. Southwest
6.4.1. Southwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5. Northeast
6.5.1. Northeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6. West
6.6.1. West U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. CVS Health
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Kroger Health
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Walgreens
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Advocate Health Care
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Kaiser Foundation Health Plan, Inc.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Walmart
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Bellin Health Systems
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Geisinger Health
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Target
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. RETAIL CLINICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Retail Clinics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. U.S. RETAIL CLINICS MARKET: OWNERSHIP ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Retail Clinics Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
4.3. Retail Owned
4.3.1. Retail Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4. Hospital Owned
4.4.1. Hospital Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 5. U.S. RETAIL CLINICS MARKET: DIAGNOSIS ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Retail Clinics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
5.3. Immunization
5.3.1. Immunization Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. General Symptoms
5.4.1. General Symptoms Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5. Injuries
5.5.1. Injuries Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6. General Screening & Examination
5.6.1. General Screening & Examination Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.7. Acute Respiratory Disease & Infection
5.7.1. Acute Respiratory Disease & Infection Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.8. Urinary Tract Infections
5.8.1. Urinary Tract Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.9. Ear Infections
5.9.1. Ear Infections Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.10. Sprains, Strains, and Fractures
5.10.1. Sprains, Strains, and Fractures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.11. Others
5.11.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 6. U.S. RETAIL CLINICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. U.S. Retail Clinics Market Share, By Region, 2023 & 2030, USD Million
6.2. Southeast
6.2.1. Southeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3. Midwest
6.3.1. Midwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4. Southwest
6.4.1. Southwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5. Northeast
6.5.1. Northeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6. West
6.6.1. West U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. CVS Health
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Kroger Health
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Walgreens
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Advocate Health Care
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Kaiser Foundation Health Plan, Inc.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Walmart
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Bellin Health Systems
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Geisinger Health
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Target
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
